Skip to main content
ALMR
NASDAQ Life Sciences

Alamar Launches National Biomarker Initiative for Alzheimer's with Top Universities

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$28.42
Mkt Cap
$1.97B
52W Low
$18.845
52W High
$28.68
52W Position info
51% above low
Off High info
at 52W high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ALMR sits 51% above its 52-week low of $18.845.

Summary

Alamar Biosciences is partnering with leading research universities to launch a national-scale proteomics initiative using its NULISAseq Neuro 220 panel. The project will profile approximately 21,000 plasma samples from 10,000 Alzheimer's Disease and Related Dementias participants, generating a large, publicly accessible dataset linked to NACC IDs. This collaboration, part of the CLARiTI portfolio, leverages academic and philanthropic partnerships and includes an AI-driven data challenge. The initiative validates Alamar's platform at scale and positions it as a key player in neurodegenerative biomarker discovery, potentially accelerating adoption and future revenue. The stock is trading near its 52-week high, reflecting strong post-IPO momentum.

At the time of this announcement, ALMR was trading at $28.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $18.85 to $28.68. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ALMR - Latest Insights

ALMR
Nov 03, 2026, 9:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.00
Real-time Price: $30.81 info
Change: +$0.810 (+3%) info
Market Cap: $2.141B info
ALMR
Nov 03, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.50
Real-time Price: $30.81 info
Change: -$0.690 (-2%) info
Market Cap: $2.141B info
ALMR
Nov 03, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $31.50
Real-time Price: $30.81 info
Change: -$0.690 (-2%) info
Market Cap: $2.141B info
ALMR
Oct 14, 2026, 8:20 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $25.37
Real-time Price: $30.81 info
Change: +$5.44 (+21%) info
Market Cap: $2.141B info
ALMR
Aug 11, 2026, 1:25 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $36.44
Real-time Price: $30.81 info
Change: -$5.63 (-15%) info
Market Cap: $2.141B info